ECSP972034A - SYNTHETIC GENES HIV - Google Patents
SYNTHETIC GENES HIVInfo
- Publication number
- ECSP972034A ECSP972034A ECSP972034A ECSP972034A EC SP972034 A ECSP972034 A EC SP972034A EC SP972034 A ECSP972034 A EC SP972034A EC SP972034 A ECSP972034 A EC SP972034A
- Authority
- EC
- Ecuador
- Prior art keywords
- hiv
- synthetic
- synthetic genes
- genes
- codons
- Prior art date
Links
- 108700005078 Synthetic Genes Proteins 0.000 title 1
- 108020004705 Codon Proteins 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 abstract 1
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se suministran las moléculas sintéticas de ADN que codifican los genes VIH, y las modificaciones de los genes VIH. Los codones de las moléculas sintéticas usan codones preferidos por la célula huésped proyectada. Las moléculas sintéticas pueden ser usadas como una vacuna de polinucleótido, que suministra inmunoprofilaxis efectiva contra la infección VIH, a través del anticuerpo neutralizante y la inmunidad mediada por la célula.Synthetic DNA molecules encoding HIV genes, and modifications of HIV genes are supplied. Codons of synthetic molecules use codons preferred by the projected host cell. The synthetic molecules can be used as a polynucleotide vaccine, which provides effective immunoprophylaxis against HIV infection, through the neutralizing antibody and cell-mediated immunity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972034 ECSP972034A (en) | 1997-02-21 | 1997-02-21 | SYNTHETIC GENES HIV |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972034 ECSP972034A (en) | 1997-02-21 | 1997-02-21 | SYNTHETIC GENES HIV |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972034A true ECSP972034A (en) | 1998-07-23 |
Family
ID=42042867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972034 ECSP972034A (en) | 1997-02-21 | 1997-02-21 | SYNTHETIC GENES HIV |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972034A (en) |
-
1997
- 1997-02-21 EC ECSP972034 patent/ECSP972034A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0969862T3 (en) | Synthetic HIV gag genes | |
| AR005930A1 (en) | SYNTHETIC HIV GENES, RELATED VACCINE COMPOSITIONS AND METHOD FOR INCREASING DNA EXPRESSION | |
| PT1212358E (en) | SYNTHETIC GENES OF HUMAN PAPILOMAVIRUS | |
| ES2156110T3 (en) | ANALOGS OF COLERA TOXIN SUB-UNITS DERIVED FROM RECOMBINANT DNA. | |
| CO5070674A1 (en) | VACCINES WITH A CPG OLIGONUCLEOTIDE AS AN ASSISTANT | |
| ES2173314T3 (en) | METHODS AND COMPOSITIONS FOR THE SELECTIVE MODIFICATION OF NUCLEIC ACIDS. | |
| ES2156641T3 (en) | DETERGENT COSMETIC COMPOSITIONS AND USE. | |
| DK1252323T3 (en) | Virus strains for the oncolytic treatment of cancer | |
| MX9203458A (en) | IMMUNOGENIC SEGMENTS CONTAINING CHEMICAL GLYCOPROTEINS FROM HUMAN RESPIRATORY SYNCITIAL VIRUS GLYCOPROTEINS. | |
| ECSP093601A (en) | PROTEINS DERIVED FROM THE WHITE SPOT SYNDROME VIRUS AND ITS USES | |
| ATE334216T1 (en) | VACCINE AGAINST FELINE IMMUNODEFICIENCY VIRUS | |
| AR009947A1 (en) | VACCINE COMPOSITION FOR EQUIDES WHICH ALSO INCLUDE A VACCINATION VEHICLE. | |
| MX9204685A (en) | DNA SEQUENCE CODING AN EXTERNAL SURFACE PROTEIN (OSPA) OR DERIVED FROM THE SAME VACCINE COMPOSITION QE INCLUDES SUCH PROTEIN. | |
| AR046835A1 (en) | OPTIMIZED EXPRESSION OF L1 HPV58 IN YEAST | |
| ES2151506T3 (en) | RECOMBINANT DNA MOLECULES THAT CODIFY AMYNOPEPTIDASE ENZYMES AND THEIR USE IN THE PREPARATION OF VACCINES AGAINST INFECTIONS BY HELMINS. | |
| WO2002032943A3 (en) | Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization | |
| AR024771A1 (en) | EFFECTIVE GENES AND VACCINES AGAINST FELINE CALICIVIROSIS, IN PARTICULAR RECOMBINANT VACCINES | |
| BR0015538B1 (en) | use of polysiloxanes with quaternary amino groups as formulation aids, agents containing them, as well as single dose polypropylene tubes containing said agents. | |
| ES2286212T3 (en) | SPECIFICALLY DELETED SEQUENCES OF THE MYCOBACTERIUM TUBERCULOSIS GENOME, AND ITS USE IN THE DIAGNOSIS AND AS VACCINES. | |
| FR2771751B1 (en) | ERYTHROVIRUS AND ITS APPLICATIONS | |
| ECSP972034A (en) | SYNTHETIC GENES HIV | |
| PT1272652E (en) | HERPES VIRUS FOR IMMUNITY MODULATION | |
| ES2188802T3 (en) | VIRIC VECTORS OF CONDITIONAL REPLICATION AND ITS USE. | |
| ATE346087T1 (en) | SWINE HEPATITIS E VIRUS AND ITS USES | |
| AR022662A1 (en) | NUCLEIC ACIDS AND PROTEINS OF THE MYCOPLASMA HYOPNEUMONIAE GEN MHP3 AND ITS USES |